Tweets
What do incretins have to do with inflammation?
Hear Dr. Leonard Calabrese’s “How Incretins Quench Inflammation” on Jan 30 at https://t.co/9THCAABeZ0. Kick off 2027 with rheumatology CME Jan 30–31 in Irving, TX, or live online.
Early-bird pricing through Dec 15. https://t.co/dUrUuCz2Oc
Links:
Dr. John Cush @RheumNow ( View Tweet )
31 minutes 51 seconds ago
Sjögren’s and SOB? Think About ILD!
While we excitedly await FDA approval of novel immunotherapies, it is worth reminding ourselves that the new drugs will be indicated primarily for patients with active systemic manifestations of SjD that is of at least moderate severity based https://t.co/T51dAyRpcw
Dr. John Cush @RheumNow ( View Tweet )
3 hours 1 minute ago
CD19 CAR-T Relapse: 7 of 50 in Erlangen, Rescued With BCMA
Relapse after CD19 CAR-T was rare in lupus and common in anti-synthetase syndrome and Scl-70 scleroderma. Six of seven relapsing patients were treated with BCMA-directed therapy and responded again. https://t.co/SCD9wZ5DVa
Dr. John Cush @RheumNow ( View Tweet )
4 hours 31 minutes ago
GLP-1 Keeps on Working in PsA
Dr. David Liew | Abstract 2942 | ACR 2026
https://t.co/9lzyNq0RyS https://t.co/E7gjUj6Tgx
Dr. John Cush @RheumNow ( View Tweet )
23 hours 31 minutes ago
New FDA Approved for Polymyalgia Rheumatica - Secukinumab
The US Food and Drug Administration (FDA) approved secukinumab (Cosentyx) for the treatment of adults with polymyalgia rheumatica (PMR) who have had an inadequate response to corticosteroids or who cannot tolerate a https://t.co/kmgEiZIiFS
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
A Look Ahead: Precision, Safety and Access as Therapies Grow More Complex
ACR Convergence 2026 closed on a high note with the Clinical Year in Preview, a forward-looking session on the final day presented by Alexis Ogdie, MD, MSCE, of the University of Pennsylvania. https://t.co/br5LBqkqeu
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
Conducting a CAR-T Trial: A Pediatric Rheumatologist’s Reflections
At #ACR26, a scientific session titled “Program and Ethical Readiness in Pediatric Rheumatology: Building CAR Therapy Pathways for Rare Disease Care” addressed our readiness as a field for CAR-based therapies. https://t.co/qYWKJtTxmZ
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
One dose for every body? Rethinking drug exposure
Dr. Jiha Lee | Size Matters Session | ACR 2026
https://t.co/zodmhAZm1e https://t.co/kkBrQNmwXW
Dr. John Cush @RheumNow ( View Tweet )
1 day 21 hours ago
Top 6 Practice-Changing Highlights from ACR26
The content at ACR Orlando was vast. We looked at several posters/listened to many talks, and heard from colleagues. So if we missed some great abstracts that will be practice-changing for you, we apologize in advance.
Here is our https://t.co/JmRpPh8Wzi
Dr. John Cush @RheumNow ( View Tweet )
1 day 23 hours ago
Does a Gout Flare Increase Risk of a Cardiovascular Event?
In 2022, Cipolletta and colleagues published a JAMA study showing a temporal association between gout flares and subsequent major adverse cardiovascular events (MACE). This study reported 93% higher odds of MACE in the https://t.co/G91c9oz7tP
Dr. John Cush @RheumNow ( View Tweet )
2 days ago
Who benefits from GLP-1s in your rheumatology clinic?
Hear Dr. Catherine Bakewell tackle that question on Jan 30 at https://t.co/9THCAABeZ0. Kick off 2027 with rheumatology CME Jan 30–31 in Irving, TX, or live online.
Early-bird pricing through Dec 15. https://t.co/xjuAWKqAY9 https://t.co/9Nwx85xIb6
Dr. John Cush @RheumNow ( View Tweet )
2 days ago
Low PREVENT Score, Real Risk: Coronary Calcium and Heart Failure in Lupus
Dr. Akhil Sood | Abstracts 2861 0922 | ACR 2026
https://t.co/hREBmSbDQK https://t.co/wuiriT45zs
Dr. John Cush @RheumNow ( View Tweet )
2 days ago
Who gets left behind by the new SpA Criteria
Dr. Henrique Dalmolin & Dr. Carla Saad & Dr. Licia Mota | ACR 2026
https://t.co/SJhUVCZ8aZ https://t.co/vpe7ASo82Q
Dr. John Cush @RheumNow ( View Tweet )
2 days 17 hours ago
Biologics vs JAKi: MACE and VTE Risk in PsA
Dr. Sheila Reyes & Dr. Marina Magrey | Abstract 2304 | ACR 2026
https://t.co/IzafHHg9Me https://t.co/PGfQOk882R
Dr. John Cush @RheumNow ( View Tweet )
2 days 18 hours ago
JAKi CV Safety in Younger Adults
https://t.co/Cp7YEz0277 https://t.co/oBGRQjBuoH
Dr. John Cush @RheumNow ( View Tweet )
2 days 19 hours ago
